Clinical Trials for Zealand Pharma

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Zealand Pharma

Clinical Trials (9)

NCT07197944
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
PHASE3Not yet recruiting
90 participants
Started: Oct 23, 2025 · Completed: Feb 28, 2032
1 condition1 sponsor0 locations
NCT06926842
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
PHASE2Recruiting
216 participants
Started: Apr 22, 2025 · Completed: Jun 4, 2026
3 conditions2 sponsors25 locations
NCT07076030
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
PHASE1Recruiting
48 participants
Started: Apr 15, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06662539
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
PHASE2Active, not recruiting
494 participants
Started: Dec 9, 2024 · Completed: Mar 16, 2026
1 condition2 sponsors32 locations
NCT06682975
A Research Study Looking at the Safety of Single Doses of ZP9830 and How it Works in the Body of Healthy Participants
PHASE1Recruiting
92 participants
Started: Nov 12, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05788601
Dapiglutide for the Treatment of Obesity
PHASE2Active, not recruiting
54 participants
Started: Apr 27, 2023 · Completed: Aug 15, 2025
2 conditions2 sponsors1 location
NCT04881825
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
PHASE3Enrolling by invitation
129 participants
Started: Jun 16, 2021 · Completed: Apr 30, 2025
1 condition1 sponsor19 locations
NCT03905707
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
PHASE3Active, not recruiting
145 participants
Started: May 7, 2019 · Completed: Oct 31, 2026
1 condition1 sponsor27 locations
NCT03941236
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism
PHASE3Active, not recruiting
44 participants
Started: May 1, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor10 locations